CCL Products (India) Limited has filed a regulatory disclosure regarding the exercise of employee stock options under its ESOP scheme. The disclosure is made pursuant to Regulation 10 of the Securities and Exchange Board of India (Share Based Employee Benefits and Sweat Equity) Regulations, 2021.
Key Quantitative Details
- Number of shares issued: 4,200
- Face value per share: ₹2
- Exercise price per share: ₹2
- Premium per share: Nil
- Distinctive number range: 133331140 to 133335339
- Exercise date: 03-08-2026
Capital Structure Impact
The disclosure confirms that the allotted shares rank pari-passu with the existing shares of the company. There is no change in the paid-up share capital of the company subsequent to this transfer. The total issued shares remain at 13,35,27,920 equity shares, and the total issued share capital remains at ₹26,70,55,840 divided into 13,35,27,920 shares of ₹2 each.
Regulatory Compliance Details
The filing references previous statements filed with the stock exchanges:
- For 4,00,000 shares: NSE on 23.09.2022 (Filing Number: NSE/LIST/32675), BSE on 22.09.2022 (Filing Number: DCS/IPO/MJ/ESOPIP/2501/2022-23)
- For 1,00,000 shares: NSE on 09.02.2024 (Filing Number: NSE/LIST/39980), BSE on 09.02.2024 (Filing Number: DCS/IPO/JP/ESOPIP/3107/2023-24)
Additional Information
- Shares are issued in demat form (no physical certificates)
- No lock-in period applies to the shares
- No listing fees are payable for this issuance
- The shares are identical in all respects to existing shares